Physical monitoring of repair process of chromosomal double stand break induced by simultaneous nuclear introduction of I-SceI endonuclease
I-SceI核酸内切酶同时入核诱导染色体双链断裂修复过程的物理监测
基本信息
- 批准号:15590259
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In this study we tried to develop a method to simultaneously introduce a single double strand DNA break (DSB) into defined chromosomal locus. If this is made possible, then we would be able to continuously monitor physical status of the ends by genomic Southern blotting, recruitment of repair and/or checkpoint factors, progression of the repair process itself and so on. In yeast cells, such technology is available and contributes enormously to our understanding of the basic process of the DSB repair.To this end, we plan to use rare restriction endonuclease I-SceI and cells harbouring the18 base-pair specific recognition sequence in its chromosome. The DSB is introduced in the integrated recombination substrate SCneo by I-SceI, and the repair efficiency can be determined by conversion of the G418-sensitive cells to resistant cells. To introduce I-SceI in high efficiency and in a synchronous manner, the I-SceI coding sequence was fused with two ligand binding domains of estrogen receptor … More or the protein transduction domain derived from HIV TAT sequence and 6XHis sequence for purification tag. In the former case, the fusion protein I-SceI-ER was stably expressed in a cell line. The latter case, the plasmid was introduced into E.coli and the fusion protein TAT-I-SceI was biochemically purifed.(1)We successfully expressed the I-SceI-ER in the chicken B cell line DT40, and examined localization of the protein before and after treatment with estrogen analog tamoxifen. I-SceI-ER protein was rapidly (within 15min) mobilized from cytoplasm to nucleus with high efficiency. However, relatively few DSB repair events occurred, which is consistent with the possibility that ER may interfere with the endonuclease activity. Nonetheless, this cell fine would be useful for some studies. We are now trying to improve the efficiency by making new fusion proteins.(2)We purified the recombinant TAT-I-SceI protein but the protein appeared to aggregate spontaneously. We are trying to find optimal condition to purigy and store the protein. Less
在这项研究中,我们试图开发一种方法,将单个双链DNA断裂(DSB)引入定义的染色体基因座。如果使它成为可能,那么我们将能够通过基因组南部印迹,修复和/或检查点因素,维修过程本身的进展等等,不断地监测目的的身体状态。在酵母细胞中,此类技术可用,并为我们对DSB修复的基本过程的理解做出了巨大贡献。为此,我们计划使用罕见的限制性核酸内切酶I-SCEI和具有18个基本对碱基识别序列的细胞。 DSB由I-SCEI在集成的重组底物SCNEO中引入,并且可以通过将G418敏感细胞转换为抗性细胞来确定修复效率。为了以高效率和同步的方式引入I-SCEI,将I-SCEI编码序列与雌激素受体的两个配体结合结构域融合在一起……更多或源自HIV TAT序列和6xHis序列的蛋白质转移结构域的纯化标签。在前一种情况下,融合蛋白I-SCEIER在细胞系中稳定地表达。后一种情况是将质粒引入大肠杆菌,并在生化上纯化了融合蛋白Tat-i-SCEI。(1)我们在鸡B细胞系DT40中成功表达了I-SCEI-ER,并检查了用雌激素模拟tamoxifen治疗前后蛋白质的定位。 I-SCEI-ER蛋白迅速(在15分钟内)以高效率从细胞质动员到核动员。但是,发生的DSB修复事件相对较少,这与ER可能干扰内切清除酶活性的可能性一致。但是,该细胞罚款对于某些研究将很有用。现在,我们正在尝试通过制造新的融合蛋白来提高效率。(2)我们纯化了重组Tat-I-SCEI蛋白,但该蛋白似乎是由赞助的。我们正在尝试找到最佳的纯净和存储蛋白质的条件。较少的
项目成果
期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hashimoto M. et al.: "DNA-PK : the major target for wortmannin-mediated radiosensitization by the inhibition of DSB repair via NHEJ pathway."J Radiat Res (Tokyo).. Jun;44(2). 151-159 (2003)
Hashimoto M. 等人:“DNA-PK:通过 NHEJ 途径抑制 DSB 修复来实现渥曼青霉素介导的放射增敏的主要靶标。”J Radiat Res(东京).. Jun;44(2)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sezaki N. et al.: "Over-expression of the dominant-negative isoform of Ikaros confers resistance to dexamethasone-induced and anti-IgM-induced apoptosis."Br J Haematol.. 121. 165-169 (2003)
Sezaki N. 等人:“Ikaros 显性失活亚型的过度表达赋予对地塞米松诱导的和抗 IgM 诱导的细胞凋亡的抗性。”Br J Haematol.. 121. 165-169 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sonoda E. et al.: "Multiple roles of Rev3, the catalytic subunit of polzeta in maintaining genome stability in vertebrates."EMBO J.. Jun 16;22(12). 3188-3197 (2003)
Sonoda E. 等人:“Rev3(polzeta 的催化亚基)在维持脊椎动物基因组稳定性方面的多重作用。”EMBO J.. Jun 16;22(12)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
A Novel RNA-recognition motif (RRM)-containing protein involved in the cell response to cisplatin in vertebrates.
一种包含新型 RNA 识别基序 (RRM) 的蛋白质,参与脊椎动物细胞对顺铂的反应。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Hamimes S.et al.
- 通讯作者:Hamimes S.et al.
Yamamoto K. et al.: "Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells."Mol Cell Biol. 23. 5421-5430 (2003)
Yamamoto K. 等人:“范可尼贫血 FANCG 蛋白通过脊椎动物细胞中的同源重组减轻辐射和酶诱导的 DNA 双链断裂。”Mol Cell Biol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAKATA Minoru其他文献
TAKATA Minoru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAKATA Minoru', 18)}}的其他基金
Regulatory mechanisms of CtIP nuclease during DNA crosslink repair
DNA交联修复过程中CtIP核酸酶的调控机制
- 批准号:
24310042 - 财政年份:2012
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation of protein expression using a cell cyclce-specific degron and its application to functional analysis
使用细胞周期特异性降解决定子调节蛋白质表达及其在功能分析中的应用
- 批准号:
23651046 - 财政年份:2011
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Regulation of the ubiquitin system by checkpoint kinases in response to stalled replication forks
检查点激酶对泛素系统的调节以响应停滞的复制叉
- 批准号:
21390094 - 财政年份:2009
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation of the ubiquitin system by checkpoint kinases in response to stalled replication forks
检查点激酶对泛素系统的调节以响应停滞的复制叉
- 批准号:
19390087 - 财政年份:2007
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Induction of single DNA double strand break in animal cell genome and its monitoring methodology
动物细胞基因组中单DNA双链断裂的诱导及其监测方法
- 批准号:
17590279 - 财政年份:2005
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional analysis of Fanconi anemia genes that are involved in chromosomal stability and tumor prevention
涉及染色体稳定性和肿瘤预防的范可尼贫血基因的功能分析
- 批准号:
17013083 - 财政年份:2005
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Development of new assays to evaluate cellular effects of jonizing radiation
开发新的测定方法来评估琼化辐射的细胞效应
- 批准号:
12480155 - 财政年份:2000
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analysis of genes involved in maintenance of chromosome stability and homologous recombination
参与维持染色体稳定性和同源重组的基因的功能分析
- 批准号:
12213059 - 财政年份:2000
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Molecular genetic investigation of Japanese cutaneous melanoma
日本皮肤黑色素瘤的分子遗传学研究
- 批准号:
09670868 - 财政年份:1997
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
DNA双链断裂修复蛋白DNA-PKcs致病性移码突变在机体发育和肿瘤发生中的作用
- 批准号:82372716
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
TGS1调控DNA损伤修复影响三阴性乳腺癌放疗敏感性的机制研究
- 批准号:82303696
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
iPSCs源凋亡囊泡促进RNAPII泛素化介导DNA转录偶联修复在衰老骨稳态中的机制研究
- 批准号:82301123
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PUF60通过调控SET可变多聚腺苷酸化参与DNA损伤修复促进卵巢癌耐药的机制
- 批准号:82303055
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SSRP1通过ATR增强DNA损伤修复介导骨肉瘤耐药的作用机制研究
- 批准号:82303899
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Small molecules targeting RuvBL complex for triple negative breast cancer
靶向 RuvBL 复合物的小分子治疗三阴性乳腺癌
- 批准号:
10751401 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers-- Targeting the PARP Pathway for the Prevention of Breast Cancer
PREVENT Cancer临床前药物开发计划:临床前疗效和中间终点生物标志物——靶向PARP通路预防乳腺癌
- 批准号:
10629488 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Defining and Targeting Homologous Recombination Deficiency in Breast Cancer
乳腺癌同源重组缺陷的定义和针对
- 批准号:
10478008 - 财政年份:2020
- 资助金额:
$ 2.3万 - 项目类别:
Defining and Targeting Homologous Recombination Deficiency in Breast Cancer
乳腺癌同源重组缺陷的定义和针对
- 批准号:
10237881 - 财政年份:2020
- 资助金额:
$ 2.3万 - 项目类别:
Elucidating the Mechanism of CDK4/6 Inhibitor-Mediated Radiosensitization of ER+ Breast Cancers
阐明 CDK4/6 抑制剂介导的 ER 乳腺癌放射增敏机制
- 批准号:
10222542 - 财政年份:2020
- 资助金额:
$ 2.3万 - 项目类别: